Roivant Sciences Ltd.
Director, 10% owner, Immunovant, Inc.
Bought, 12 months
$350M
Sold, 12 months
$0.0M
Companies
1
Latest trade
Dec 12, 2025
Companies
Immunovant, Inc.Director, 10% owner +$350M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.